Pubblicazioni scientifiche

Cancella testo

Open Access

31898 pubblicazioni

Forte D.; Garcia-Fernandez M.; Sanchez-Aguilera A.; Stavropoulou V.; Fielding C.; Martin-Perez D.; Lopez J.A.; Costa A.S.H.; Tronci L.; Nikitopoulou E.; Barber M.; Gallipoli P.; Marando L.; Fernandez de Castillejo C.L.; Tzankov A.; Dietmann S.; Cavo M.; Catani L.; Curti A.; Vazquez J.; Frezza C.; Huntly B.J.; Schwaller J.; Mendez-Ferrer S., Bone Marrow Mesenchymal Stem Cells Support Acute Myeloid Leukemia Bioenergetics and Enhance Antioxidant Defense and Escape from Chemotherapy, «CELL METABOLISM», 2020, 32, pp. 829 - 843 [Articolo in rivista] Open Access
Pea F., From bench to bedside: Perspectives on the utility of pharmacokinetics/pharmacodynamics in predicting the efficacy of antifungals in invasive candidiasis, «MYCOSES», 2020, 63, pp. 854 - 858 [Articolo in rivista]
Bassetti M.; Vena A.; Bouza E.; Peghin M.; Munoz P.; Righi E.; Pea F.; Lackner M.; Lass-Florl C., Antifungal susceptibility testing in Candida, Aspergillus and Cryptococcus infections: are the MICs useful for clinicians?, «CLINICAL MICROBIOLOGY AND INFECTION», 2020, 26, pp. 1024 - 1033 [Articolo in rivista]
Abdul-Aziz M.H.; Alffenaar J.-W.C.; Bassetti M.; Bracht H.; Dimopoulos G.; Marriott D.; Neely M.N.; Paiva J.-A.; Pea F.; Sjovall F.; Timsit J.F.; Udy A.A.; Wicha S.G.; Zeitlinger M.; De Waele J.J.; Roberts J.A., Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#, «INTENSIVE CARE MEDICINE», 2020, 46, pp. 1127 - 1153 [Articolo in rivista]
Cattani G.; Madia A.; Arnoldo L.; Brunelli L.; Celotto D.; Grillone L.; Valent F.; Castriotta L.; Pea F.; Bassetti M.; Brusaferro S., Assessment of the impact of clinical recommendations on antibiotic use for CAP and HCAP: results from an implementation program in an Academic Hospital, «ANNALI DI IGIENE MEDICINA PREVENTIVA E DI COMUNITÀ», 2020, 32, pp. 344 - 356 [Articolo in rivista]
Barco S.; Mesini A.; Barbagallo L.; Maffia A.; Tripodi G.; Pea F.; Saffioti C.; Castagnola E.; Cangemi G., A liquid chromatography-tandem mass spectrometry platform for the routine therapeutic drug monitoring of 14 antibiotics: Application to critically ill pediatric patients, «JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS», 2020, 186, pp. 1 - 10 [Articolo in rivista]
Cojutti P.G.; Londero A.; Della Siega P.; Givone F.; Fabris M.; Biasizzo J.; Tascini C.; Pea F., Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin-6, «CLINICAL PHARMACOKINETICS», 2020, 59, pp. 1251 - 1260 [Articolo in rivista] Open Access
Avnet S.; Lemma S.; Errani C.; Falzetti L.; Panza E.; Columbaro M.; Nanni C.; Baldini N., Benign albeit glycolytic: MCT4 expression and lactate release in giant cell tumour of bone, «BONE», 2020, 134, pp. 115302 - N/A [Articolo in rivista]
Guaraldi G.; Milic J.; Cozzi-Lepri A.; Pea F.; Mussini C., Tocilizumab in COVID-19: finding the optimal route and dose – Authors' reply, «THE LANCET. RHEUMATOLOGY», 2020, 2, pp. E739 - E740 [Replica/breve intervento (e simili)]
Minardi R.; Licchetta L.; Baroni M.C.; Pippucci T.; Stipa C.; Mostacci B.; Severi G.; Toni F.; Bergonzini L.; Carelli V.; Seri M.; Tinuper P.; Bisulli F., Whole-exome sequencing in adult patients with developmental and epileptic encephalopathy: It is never too late, «CLINICAL GENETICS», 2020, 98, pp. 477 - 485 [Articolo in rivista]
Dimartino P.; Mariani V.; Marconi C.; Minardi R.; Bramerio M.; Licchetta L.; Menghi V.; Morandi L.; Magini P.; Mongelli P.; Cardinale F.; Seri M.; Tinuper P.; Tassi L.; Pippucci T.; Bisulli F., Accurate Detection of Hot-Spot MTOR Somatic Mutations in Archival Surgical Specimens of Focal Cortical Dysplasia by Molecular Inversion Probes, «MOLECULAR DIAGNOSIS & THERAPY», 2020, 24, pp. 571 - 577 [Articolo in rivista]
Dall'Olio F.G.; Abbati F.; Facchinetti F.; Massucci M.; Melotti B.; Squadrilli A.; Buti S.; Formica F.; Tiseo M.; Ardizzoni A., CEA and CYFRA 21-1 as prognostic biomarker and as a tool for treatment monitoring in advanced NSCLC treated with immune checkpoint inhibitors, «THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY», 2020, 12, pp. 1 - 4 [Articolo in rivista] Open Access
Lamberti G.; Sisi M.; Andrini E.; Palladini A.; Giunchi F.; Lollini P.-L.; Ardizzoni A.; Gelsomino F., The mechanisms of PD-L1 regulation in non-small-cell lung cancer (NSCLC): Which are the involved players?, «CANCERS», 2020, 12, pp. 1 - 21 [Articolo in rivista] Open Access
Cojutti P.G.; Lazzarotto D.; Candoni A.; Dubbini M.V.; Zannier M.E.; Fanin R.; Pea F., Real-Time TDM-based optimization of continuous-infusion meropenem for improving treatment outcome of febrile neutropenia in oncohaematological patients: Results from a prospective, monocentric, interventional study, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2020, 75, pp. 3029 - 3037 [Articolo in rivista] Open Access
Lamberti G.; Andrini E.; Sisi M.; Rizzo A.; Parisi C.; Di Federico A.; Gelsomino F.; Ardizzoni A., Beyond EGFR, ALK and ROS1: Current evidence and future perspectives on newly targetable oncogenic drivers in lung adenocarcinoma, «CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY», 2020, 156, pp. 1 - 18 [Articolo in rivista]
Pea F., Teicoplanin and therapeutic drug monitoring: An update for optimal use in different patient populations, «JOURNAL OF INFECTION AND CHEMOTHERAPY», 2020, 26, pp. 900 - 907 [Articolo in rivista]
Parisi C.; Lamberti G.; Zompatori M.; Gelsomino F.; Salvagni S.; Sperandi F.; Ardizzoni A., Evolution of cystic airspaces lung lesions on immune checkpoint inhibition in non-small cell lung cancer, «JOURNAL FOR IMMUNOTHERAPY OF CANCER», 2020, 8, pp. 1 - 3 [Articolo in rivista] Open Access
Soriano A.; Rossolini G.M.; Pea F., The role of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs), «EXPERT REVIEW OF ANTI-INFECTIVE THERAPY», 2020, 18, pp. 415 - 422 [Articolo in rivista] Open Access
Sartore-Bianchi A.; Lonardi S.; Martino C.; Fenocchio E.; Tosi F.; Ghezzi S.; Leone F.; Bergamo F.; Zagonel V.; Ciardiello F.; Ardizzoni A.; Amatu A.; Bencardino K.; Valtorta E.; Grassi E.; Torri V.; Bonoldi E.; Sapino A.; Vanzulli A.; Regge D.; Cappello G.; Bardelli A.; Trusolino L.; Marsoni S.; Siena S., Pertuzumab and trastuzumab emtansine in patients with HER2-amplified metastatic colorectal cancer: The phase II HERACLES-B trial, «ESMO OPEN», 2020, 5, pp. 1 - 8 [Articolo in rivista] Open Access
Dall'Olio F.G.; Conci N.; Rossi G.; Fiorentino M.; De Giglio A.; Grilli G.; Altimari A.; Gruppioni E.; Filippini D.M.; Di Federico A.; Nuvola G.; Ardizzoni A., Comparison of Sequential Testing and Next Generation Sequencing in advanced Lung Adenocarcinoma patients – A single centre experience, «LUNG CANCER», 2020, 149, pp. 5 - 9 [Articolo in rivista]